Literature DB >> 17041404

Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome.

Cornelia R Ciubotaru1, Fraydoon Esfahani, Ralph H B Benedict, Linda M Wild, Alan N Baer.   

Abstract

Antiphospholipid antibodies are associated with a variety of neurologic manifestations, both in patients with and without concomitant systemic lupus erythematosus. We report a patient in whom chorea and rapidly progressive subcortical dementia developed in the setting of persistently high titers of antiphospholipid antibodies. While some manifestations of antiphospholipid syndrome can be clearly linked to vascular thrombosis, it is not known whether this is also true for patients affected with chorea, dementia, or both. In our patient, serial magnetic resonance imaging showed the progressive development of deep white matter lesions but no cortical infarcts. The development of widespread pulmonary arterial thrombosis and acute cerebral ischemia, evidenced clinically and on diffusion-weighted magnetic resonance imaging of the brain, provided indirect evidence for a thrombotic pathogenesis for this patient's neurologic disease. Anticoagulation should be considered as an adjunct to the treatment of patients with antiphospholipid antibodies and chorea or subcortical dementia.

Entities:  

Year:  2002        PMID: 17041404     DOI: 10.1097/00124743-200212000-00010

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  6 in total

Review 1.  Diagnosis and treatment of chorea syndromes.

Authors:  Andreas Hermann; Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2015       Impact factor: 5.081

Review 2.  Differential diagnosis of chorea.

Authors:  Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

3.  Case of a Man with Hemichorea and Behavioral Changes: "A Red Herring".

Authors:  Galit Kleiner; Stephen A Ryan; Juan Bilbao; Julia Keith; Ekaterina Rogaeva; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Mov Disord Clin Pract       Date:  2022-03-30

Review 4.  Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Authors:  Mohammad Hassan A Noureldine; Ali A Haydar; Ahmad Berjawi; Rody Elnawar; Ahmad Sweid; Munther A Khamashta; Graham R V Hughes; Imad Uthman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

5.  Presence of Anticardiolipin Antibodies in Patients with Dementia: A Systematic Review and Meta-Analysis.

Authors:  Md Asiful Islam; Fahmida Alam; Mohammad Amjad Kamal; Siew Hua Gan; Teguh Haryo Sasongko; Kah Keng Wong
Journal:  Front Aging Neurosci       Date:  2017-08-02       Impact factor: 5.750

6.  Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Authors:  Maria Mialdea; Shirish R Sangle; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2009-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.